Anna N. A. Tosteson, ScD
Title(s)
Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology
Additional Titles/Positions/Affiliations
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Dartmouth Cancer Center
Principal Investigator, SYNERGY, Dartmouth's Clinical and Translational Science Institute
Department(s)
The Dartmouth Institute
Medicine
Community and Family Medicine
Education
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS
Programs
Dartmouth Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice
Contact Information
Geisel School of Medicine at Dartmouth
HB7505
One Medical Center Drive
Lebanon NH 03756
Office: WTRB 526, DHMC
Phone: 603-646-5664
Email: Anna.Tosteson@dartmouth.edu
Assistant: Christopher Jacobs
Asst. Phone: 603-646-5237
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU
Professional Interests
Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, electronic health record data, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.
Grant Information
Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )
Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)
Courses Taught
PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis
Oncology Physician Turnover in the United States Based on Medicare Claims Data. Supplemental breast cancer screening after negative mammography in U.S. women with dense breasts. Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test Results. Travel burden and bypassing closest site for surgical cancer treatment for urban and rural oncology patients. Testing a Breast Cancer Screening Decision aid Designed for Health Literacy Accessibility. Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort. Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density. Relative Timing of Mammography and MRI for Breast Cancer Screening: Impact on Performance Evaluation. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force. Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer. |
|